Search Within

Jaclyn Frances Hechtman

  1. "Biostatistics Service"
Formats
  1. Journal Article (24)
  2. Meeting Abstract (10)
Groups
  1. Biostatistics Service (34)
  2. Epidemiology and Biostatistics (34)
  3. Department of Medicine (33)
  4. Solid Tumor Oncology Division (33)
  5. GSK Faculty (30)
  6. Center for Pancreatic Cancer Research (28)

More Groups

People
  1. Nikolaus Schultz (23)
  2. David Solit (20)
  3. Marinela Capanu (20)
  4. Michael Berger (16)
  5. Yelena Janjigian (16)
  6. Geoffrey Ku (14)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (3)
  4. 2020 (5)
  5. 2019 (10)
  6. 2018 (4)

More Years

Publications
  1. Clinical Cancer Research (9)
  2. Journal of Clinical Oncology (5)
  3. Annals of Oncology (3)
  4. Modern Pathology (3)
  5. Cancer Discovery (2)
  6. Annals of Surgical Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (11)
  2. American Society of Clinical Oncology (6)
  3. Oxford University Press (4)
  4. Nature Research (3)
  5. Elsevier Inc. (2)
  6. Nature Publishing Group (2)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S.; Chou, J. F.; Gabler, A. R.; Simmons, M. Z.; Momtaz, P.; Shcherba, M.; Ku, G. Y.; Won, E.; Sanchez-Vega, F.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)
    Meeting Abstract

    Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical and molecular predictors of response to immune checkpoint inhibitors in patients with advanced esophagogastric cancer
    Journal Article

    Greally, M.; Chou, J. F.; Chatila, W. K.; Margolis, M.; Capanu, M.; Hechtman, J. F.; Tuvy, Y.; Kundra, R.; Daian, F.; Ladanyi, M.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Efficacy of combined VEGFR1-3, PDGFα/β, and FGFR1-3 blockade using nintedanib for esophagogastric cancer
    Journal Article

    Won, E.; Basunia, A.; Chatila, W. K.; Hechtman, J. F.; Chou, J. F.; Ku, G. Y.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
    Journal Article

    Mondaca, S.; Margolis, M.; Sanchez-Vega, F.; Jonsson, P.; Riches, J. C.; Ku, G. Y.; Hechtman, J. F.; Tuvy, Y.; Berger, M. F.; Shah, M. A.; more...
    Gastric Cancer (2019)

    Fulltext@MSK | Save
  • FOLFCIS treatment and genomic correlates of response in advanced anal squamous cell cancer
    Journal Article

    Mondaca, S.; Chatila, W. K.; Bates, D.; Hechtman, J. F.; Cercek, A.; Segal, N. H.; Stadler, Z. K.; Varghese, A. M.; Kundra, R.; Capanu, M.; more...
    Clinical Colorectal Cancer (2019)

    Fulltext@MSK | Save
  • Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma
    Journal Article

    Audenet, F.; Isharwal, S.; Cha, E. K.; Donoghue, M. T. A.; Drill, E. N.; Ostrovnaya, I.; Pietzak, E. J.; Sfakianos, J. P.; Bagrodia, A.; Murugan, P.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • EGFR and MET amplifications determine response to HER2 inhibition in ERBB2-amplified esophagogastric cancer
    Journal Article

    Sanchez-Vega, F.; Hechtman, J. F.; Castel, P.; Ku, G. Y.; Tuvy, Y.; Won, H.; Fong, C. J.; Bouvier, N.; Nanjangud, G. J.; Soong, J.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomas
    Journal Article

    Liu, S.; Gӧnen, M.; Stadler, Z. K.; Weiser, M. R.; Hechtman, J. F.; Vakiani, E.; Wang, T.; Vyas, M.; Joneja, U.; Al-Bayati, M.; more...
    Modern Pathology (2019)

    Fulltext@MSK | Save